Fund to Support Cancer Research at Brigham & Women’s


To honor the memory of our beloved colleague, Susanne Englert Coyne, Fiduciary Trust Company has established The Susanne Englert Coyne Fund to support the Women’s Lung Cancer Program at Brigham & Women’s Hospital with an initial gift of $25,000. Lung cancer is a leading cause of cancer-related deaths among women, and approximately 20% of women diagnosed with lung cancer never smoked.

This gift will support the research of Dr. Yolonda Colson, Director of the Women’s Lung Cancer Program, on the features, treatment response and risk recurrence of lung cancer among female never-smokers. Specifically, Dr. Colson will enlist a multi-disciplinary team of clinical experts and data analysts to construct a comprehensive database to accurately capture the clinical, radiographic and surgical characteristics of all women identified with a suspicious lung nodule at Brigham & Women’s or the Dana Farber Cancer Institute. In addition, the gift will fund quantitative imaging and tissue analysis that will inform a risk-stratification model for female never-smokers.

Additional gifts to the Fund may be made online at: or through a check payable to: “Brigham and Women’s Hospital – The Susanne Englert Coyne Fund.”

Gifts should be sent to:
Barbara Hickey Director of Constituent Development, Women’s Health
Brigham and Women’s Hospital – Development Office
116 Huntington Ave., 3rd Floor
Boston, MA 02116

Discover more about what differentiates Fiduciary Trust

Talk to a Fiduciary Trust Advisor